
USP28-IN-3
CAS No. 2931509-14-5
USP28-IN-3( —— )
Catalog No. M36611 CAS No. 2931509-14-5
USP28-IN-3 is a highly selective USP28 inhibitor with an IC50 value of 0.1 μM against USP28.USP28-IN-3 exhibits anticancer activity and inhibits USP2, USP7, USP8, USP9x, UCHL3, and UCHL5.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 278 | Get Quote |
![]() ![]() |
5MG | 377 | Get Quote |
![]() ![]() |
10MG | 562 | Get Quote |
![]() ![]() |
25MG | 975 | Get Quote |
![]() ![]() |
50MG | 1362 | Get Quote |
![]() ![]() |
100MG | 1782 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameUSP28-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionUSP28-IN-3 is a highly selective USP28 inhibitor with an IC50 value of 0.1 μM against USP28.USP28-IN-3 exhibits anticancer activity and inhibits USP2, USP7, USP8, USP9x, UCHL3, and UCHL5.
-
DescriptionUSP28-IN-3 is a USP28 inhibitor (IC50=0.1 μM) with high selectivity over USP2, USP7, USP8, USP9x, UCHL3 and UCHL5. USP28-IN-3 shows cytotoxicity against cancer cells, down-regulates the cellular level of c-Myc through ubiquitin-proteasome system. USP28-IN-3 also decreases the ankyrase-1/2 level in vitro. USP28-IN-3 enhance the sensitivity of colorectal cancer cells to Regorafenib (HY-10331).
-
In VitroWestern Blot Analysis Cell Line:Human colorectal cancer cells HCT116 and Ls174T Concentration:20 μM, 30 μM, 50 μM, and 60 μM, for Ls174T; 30 μM, 50 μM, 60 μM and 80 μM for HCT116 Incubation Time:24 h Result:Dose-dependently down-regulated the cellular level of c-Myc.
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetDUB
-
RecptorDUB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2931509-14-5
-
Formula Weight475.39
-
Molecular FormulaC23H20Cl2N2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC=C(Cl)C(=C1)C=2C=CC3=C(C2)CCNC3)C4=CC=C(C=C4Cl)S(=O)(=O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhou D, et al. Structure-based discovery of potent USP28 inhibitors derived from Vismodegib. Eur J Med Chem. 2023 Jun 5;254:115369.?
molnova catalog



related products
-
PR-619
PR-619 is a non-selective, reversible inhibitor of the deubiquitinylating enzymes (DUBs) with EC50 of 1-20 μM in a cell-free assay.
-
P22074
P22074 is a USP7 inhibitor. It is not an active antagonist like its halogenated related compounds. p22074 has antitumour activity.
-
I-138
I-138 is an orally active and potent reversible inhibitor of USP1-UAF1.I-138 induces mono-ubiquitination of FANCD2 and PCNA and inhibits USP1 auto-cleavage in cells.